(Press-News.org) MIAMI, FLORIDA (AUG. 7, 2025) – Researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have documented their use of a new RNA sequencing technology to uncover molecular drivers of cellular differentiation that could lead to better regenerative therapies. In addition to being used in the lab, the technique, Rapid Precision Run-On Sequencing (rPRO-seq), has the potential to help doctors understand patients’ disease states and response to treatment in real time.
The findings appear in two published articles in Molecular Cell. The first paper was published July 24, and the second on Aug 7.
“We saw a major bottleneck in the field of nascent RNA profiling,” said Pradeep Kumar Reddy Cingaram, Ph.D., an assistant scientist at Sylvester and first author on one of the papers.
“Existing methods, while powerful, are simply too slow and require large amounts of biological material. Imagine needing tens of millions of cells and several days just to get started—that immediately ruled out crucial research on rare cell types or precious patient biopsies,” he said.
Testing rPRO-Seq
In the first study, the team used rPRO-seq to study the role of a protein complex called Integrator in regulating gene expression, which was previously untraceable with nascent RNA sequencing.
“INTS11, the catalytic subunit of Integrator complex, was a compelling choice for us because we already knew it was a key player in gene regulation,” said Cingaram.
Using cellular reprogramming models to induce neuronal differentiation, they found that when INTS11 was removed from neuronal cells, gene activity tied to brain development changed dramatically. Genes that needed to be active in order to prevent neurodevelopmental and psychiatric disorders were deactivated when the scientists removed INTS11.
“rPRO-seq allowed us to pinpoint a critical role for the INTS11 protein as a regulator of genes involved in neurodevelopmental disorders in neuronal cells,” said Ramin Shiekhattar, Ph.D., senior author on both of the studies, co-leader of the Cancer Epigenetics Program at Sylvester and chief of the Division for Cancer Genomics and Epigenomics and the Eugenia J. Dodson Chair in Cancer Research.
The technique only required 12 hours and 5,000 cells. Existing technologies needed several days and millions of cells. Additionally, the scientists emphasize that rPRO-seq allowed them to understand not just when genes were turned on and off, but how. “That is, rPRO-seq allows mechanistic understanding of gene expression changes,” said Shiekhattar.
“Standard RNA sequencing looks at 'steady-state' RNA – the accumulation of what's been made. It's like seeing how many cars are on the road. But rPRO-seq reveals 'nascent' RNA – what's being made right now. It's like watching cars leave the factory. This gives us crucial, real-time insights into active gene transcription,” said Cingaram.
INTS11 in Regenerative Medicine
Next, the team used rPRO-seq to study the role that INTS11 plays in stem cells’ ability to differentiate into any kind of cell in the body, a characteristic called pluripotency. They found that the protein began playing a critical role in gene regulation as early as day two of embryonic development.
“This greatly expands our understanding of how pluripotency and differentiation are harmonized at the molecular level,” said Shiekhattar.
Using a lab model, they found that the Integrator complex binds and regulates critical genes for stem cell identity essential for maintaining pluripotency. Additionally, “the work is paradigm shifting as it places Integrator complex at the earliest steps in transcriptional cycle, known as ‘initiation,’ compelling a revision of current theories for transcriptional initiation,” said Shiekhattar.
While both findings regarding the role of INTS11 in early development are major steps in understanding cellular differentiation, the scientists point out that the rPRO-seq could be used for many more research and clinical purposes, such as sampling a tumor to see how it’s responding to therapy.
“We’re keen to apply rPRO-seq to a wider array of human clinical samples. This would allow us to validate its utility as a diagnostic or prognostic tool and potentially uncover novel, unstable RNA biomarkers that are currently invisible to existing technologies,” said Cingaram.
“Overall, rPRO-seq could emerge as a valuable tool for both research and clinical settings, expanding the scope of transcriptomic analyses and enabling more precise, individualized health care,” added Shiekhattar.
about Sylvester research on the InventUM blog and follow @SylvesterCancer on X for the latest news on its research and care.
# # #
Authors: A complete listing of authors is available in the papers.
Article Title: “Enhancing transcriptome mapping with rapid PRO-seq profiling of nascent RNA”
DOI: 10.1016/j.molcel.2025.06.029
==
Article Title: “Integrator promotes the association of TFIID and RNA polymerase II to maintain pluripotency during development”
DOI: 10.1016/j.molcel.2025.07.006
Funding and Disclosures: Funding information and disclosures are included in the two published articles.
# # #
END
Early withdrawal of a treatment for patients with a rare kidney disease is possible without relapse, safer for patients and saves the NHS millions of pounds, new research has revealed.
Atypical Haemolytic Uraemic Syndrome (aHUS) is a life-threatening condition caused by an uncommon defect in the immune system which, in the past, led to kidney failure.
Newcastle University worked with Newcastle Hospitals to carry out clinical trials into the pioneering drug, eculizumab, which led to the NHS approving the treatment from 2015, positively transforming the outlook for patients with the ...
CHICAGO—August 7, 2025—Illinois Institute of Technology (Illinois Tech) hosted the third annual EV Readiness Community Award Ceremony this week, celebrating 17 local governments across northern Illinois for their leadership in preparing for the transition to electric vehicles (EVs). The ceremony, co-led by ComEd and the Metropolitan Mayors Caucus, brought together mayors, municipal leaders, industry experts, and elected officials to recognize communities that have earned EV Ready designations through actionable local policy, planning, and infrastructure.
The event featured remarks from Chicago Mayor Brandon Johnson, Senator Dick Durbin, ...
When bacteria battle for survival, they do so with microscopic precision. Some produce toxins that target rival microbes, shaping not only their own fitness but the structure of entire microbial communities. Marcos de Moraes, assistant professor of biosciences at Rice University, is fascinated by these microbial skirmishes and how they might be harnessed for biotechnology.
Now, with support from the National Science Foundation (NSF) Faculty Early Career Development Program (CAREER), de Moraes will study a little-understood family of bacterial toxins known as deaminases. The five-year, $1.2 million grant will fund research into the molecular ...
New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) shows, among people recently diagnosed with type with type 2 diabetes and no previous cardiovascular disease, a clear association exists between a person’s self-reported physical activity and their risk of all-cause mortality and major adverse cardiac events (MACE), that include heart attacks and strokes. The study is by Ms Line Eriksen and Dr Sidsel Domazet, Steno Diabetes Centre Odense, Odense University ...
PHILADELPHIA— For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening side effects in those who carry certain genetic variants that can impact how their bodies process the drugs used to treat their disease. Testing for variants in two genes before starting chemotherapy can significantly improve patient safety by providing physicians with information to help tailor doses, according to new research from the Perelman School of Medicine at the University ...
Glaciers carved the deep valleys of Banff, eroded Ontario to deposit the fertile soils of the Prairies and continue to change the Earth’s surface. But how fast do glaciers sculpt the landscape?
Published today in Nature Geoscience, University of Victoria (UVic) geographer Sophie Norris and her international team provide the most comprehensive view of how fast glaciers erode, and how they change the landscape. Most importantly, their research also provides an estimate of the rate of future erosion for more than 180,000 glaciers worldwide.
Using ...
The Barcelona CryoZoo is a one-of-a-kind project aiming to safeguard and study biological material from a wide range of animal species – especially those at risk of extinction – in order to preserve and better understand the planet’s biodiversity.
Born out of an initiative by the Barcelona Zoo Foundation, a space managed by BSM through the Barcelona Zoo Foundation, and that is developed jointly with University Pompeu Fabra (UPF), EMBL Barcelona, and the Natural Science Museum of Barcelona, CryoZoo has now been awarded a competitive grant from the wildlife conservation organisation Revive & Restore. This support ...
Scientists blocked a newly discovered anaphylaxis pathway in mice using Zileuton
Mice went from 95% susceptible to anaphylaxis to 95% protected
‘A totally different, out-of-the-box approach to treat food allergy’
Clinical trial recently launched to test the same approach in humans
CHICAGO --- A drug already FDA-approved for asthma was found to nearly eliminate life-threatening allergic reactions to food allergens in mice — a breakthrough that could lead to new protection for millions of people living with food allergies, reports a new Northwestern Medicine ...
FRANKFURT. Most of us find it difficult to grasp the quantum world: According to Heisenberg’s uncertainty principle, it’s like observing a dance without being able to see simultaneously exactly where someone is dancing and how fast they’re moving – you always must choose to focus on one. And yet, this quantum dance is far from chaotic; the dancers follow a strict choreography. In molecules, this strange behavior has another consequence: Even if a molecule should be completely frozen at absolute zero, it never truly comes to rest. The atoms it is made of perform a constant, never-ending quiet dance driven by so-called ...
New research in mice reveals that food-induced anaphylaxis is driven by distinct immune pathways involving inflammatory lipids called leukotrienes. The findings, published across two separate studies, identify genetic and cellular factors that influence susceptibility to severe allergic reactions and point to the potential of the drug Zileuton to block this life-threatening response. Food allergies arise when the immune system mounts an exaggerated response to certain proteins found in foods. This reaction is typically driven by Immunoglobulin E (IgE) antibodies, which recognize dietary allergens and activates mast cells throughout the body. In severe ...
